Starior Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 759.99%
- Profit Growth 139.35%
- Ebitda 48.68%
- Net Worth 56.94%
- Total Assets 132.03%
About Starior Pharma
Starior Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 January 2019 (Six years and one month 25 days old ). Its registered office is in Rangareddy, Telangana, India.
The Corporate was formerly known as Starior Life Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sandhya Vembakkam and Vijay Vembakam serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239TG2019PTC129405
- Company No.
129405
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Starior Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandhya Vembakkam  | Director | 30-Jul-2022 | Current |
| Vijay Vembakam | Director | 01-Jan-2019 | Current |
Financial Performance of Starior Pharma.
Starior Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 759.99% increase. The company also saw a substantial improvement in profitability, with a 139.35% increase in profit. The company's net worth Soared by an impressive increase of 56.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Starior Pharma?
Unlock access to Starior Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Solis Pharmaceutical Industries Private LimitedSandhya Vembakkam and Vijay Vembakam are mutual person
Solis Life Sciences Private LimitedSandhya Vembakkam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Starior Pharma?
Unlock and access historical data on people associated with Starior Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Starior Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Starior Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
